Christopher Gibson - 09 Feb 2024 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Chief Executive Officer, Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
09 Feb 2024
Transactions value $
-$32,621
Form type
4
Filing time
13 Feb 2024, 18:55:34 UTC
Previous filing
09 Feb 2024
Next filing
16 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +11.1K +1.44% $0.00 786K 09 Feb 2024 Direct F1
transaction RXRX Class A Common Stock Award $0 +333K +42.43% $0.00 1.12M 09 Feb 2024 Direct F2
transaction RXRX Class A Common Stock Tax liability -$32.6K -3.23K -0.29% $10.09 1.12M 09 Feb 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXRX Stock Option (Right to Buy) Award $0 +667K $0.00 667K 09 Feb 2024 Class A Common Stock 667K $10.09 Direct F11
holding RXRX Stock Option (Right to Buy) 814K 09 Feb 2024 Class A Common Stock 0 $8.55 Direct F4
holding RXRX Stock Option (Right to Buy) 5.44K 09 Feb 2024 Class A Common Stock 0 $11.40 Direct
holding RXRX Stock Option (Right to Buy) 408K 09 Feb 2024 Class A Common Stock 0 $11.40 Direct F5
holding RXRX Stock Option (Right to Buy) 344K 09 Feb 2024 Class A Common Stock 0 $2.48 Direct F6
holding RXRX Class B Common Stock 6.47M 09 Feb 2024 Class A Common Stock 0 $0.00 Direct F7
holding RXRX Class B Common Stock 515K 09 Feb 2024 Class A Common Stock 0 $0.00 by LAHWRAN-3 LLC F7, F8
holding RXRX Class B Common Stock 408K 09 Feb 2024 Class A Common Stock 0 $0.00 by LAHWRAN-4 LLC F7, F9
holding RXRX Class B Common Stock 119K 09 Feb 2024 Class A Common Stock 0 $0.00 by Gibson Family Trust F7, F10
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This RSU vested immediately upon the grant date.
F2 This RSU vests as to one one-sixteenth (1/16th) of the units subject the RSU on May 15, 2024 and every three months thereafter.
F3 Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
F4 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2023, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F5 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2022, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.
F6 The option, originally for 1,500,000 shares, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter.
F7 Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
F8 The shares are held by LAHWRAN-3 LLC, of which the Reporting Person is a member and a manager.
F9 The shares are held by LAHWRAN-4 LLC, of which the Reporting Person is a member and a manager.
F10 The shares are held by the Gibson Family Trust, of which the Reporting Person serves as Trustee.
F11 The option vests as to one forty-eighth (1/48th) of the shares subject to the option on March 1, 2024, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter.